Skip to main content
OpenTrials
Completed

NCT Number: NCT01510080

Acceptance and Efficacy of Live Supervision

In order to meet an existing lack of empirical studies in the field of cognitive behavioral therapy supervision, the present randomized controlled trial is aimed at comparing two different types of supervision. This study compares computer-assisted live supervision and delayed video-based supervision regarding efficacy and acceptance among therapists, patients and supervisors. The efficacy of supervision is defined on different levels such as change of psychotherapeutic competence, nondisclosure, self-efficacy, self-awareness of the supervisee as well as therapeutic alliance, supervisory alliance and therapy outcome.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Mental Disorders

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Department of Clinical Psychology and Psychotherapy of the Wolfgang Goethe University

Frankfurt am Main, Hesse, D-60486, Germany

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Supervisees

Inclusion criteria

  • Having successfully completed the interim audit
  • Having started to treat ambulant patients under supervision

Exclusion criteria

-

Patients

Inclusion criteria

  • Meeting ICD 10 criteria for a mental disorder
  • Informed consent

Exclusion criteria

  • Currently in psychotherapy
  • Suicidal tendency
  • Clinical diagnosis of alcohol or drug addiction, acute schizophrenia, schizoaffective disorder or bipolar disorder

Treatment and study plan

Computer-assisted live supervision

Behavioral

8 BITE sessions, 4 video-based sessions (each 50 minutes) during treatment of 2 patients

Other names: "bug-in-the-eye" (BITE) supervision, video-based live supervision, monitor-based live supervision

Delayed video-based supervision

Behavioral

12 video-based sessions (each 50 minutes) during treatment of 2 patients

Other names: videotape supervision

Primary outcomes

  1. Supervisory Questionnaire (SQ)

    Time frame: participants will be followed for the duration of psychotherapy, an expected average of 30 weeks

    self-report measure that assesses nondisclosure of the supervisee during supervision

  2. Supervisee Levels Questionnaire (SLQ-R)

    Time frame: participants will be followed for the duration of psychotherapy, an expected average of 30 weeks

    self-report measure that assesses self awareness, motivation and dependency- autonomy of supervisees

  3. Counseling Self-Estimate Inventory (COSE)

    Time frame: participants will be followed for the duration of psychotherapy, an expected average of 30 weeks

    self-report measure that assesses self efficacy of the supervisee

  4. Fragebogen zur Psychotherapie-Supervision Kurzform (FSPT-K)

    Time frame: participants will be followed for the duration of psychotherapy, an expected average of 30 weeks

    self-report measure that assesses level of development and supervision needs of the therapist

Secondary outcomes

  1. Helping Alliance Questionnaire (HAQ)

    Time frame: participants will be followed for the duration of psychotherapy, an expected average of 30 weeks

    self-report measure that assesses the therapeutic alliance

  2. Supervisory Working Alliance Inventory (SWAI)

    Time frame: participants will be followed for the duration of psychotherapy, an expected average of 30 weeks

    self-report measure that assesses the supervisory relationship

  3. Beck-Depression Inventory II (BDI-II)

    Time frame: participants will be followed for the duration of psychotherapy, an expected average of 30 weeks

    self-report measure that assesses depressive symptoms

  4. Beck Anxiety Inventory II (BAI)

    Time frame: participants will be followed for the duration of psychotherapy, an expected average of 30 weeks

    self-report measure that asessses anxiety symptoms

  5. Brief Symptom Inventory (BSI)

    Time frame: participants will be followed for the duration of psychotherapy, an expected average of 30 weeks

    self-report measure that assesses aspects of general psychopathology

  6. Health-related quality of life (SF-12)

    Time frame: participants will be followed for the duration of psychotherapy, an expected average of 30 weeks

    self-report measure that assesses the health-related quality of life

  7. Client Satisfaction Questionnaire (CSQ8)

    Time frame: participants will be followed for the duration of psychotherapy, an expected average of 30 weeks

    self-report measure that assesses satisfaction with therapy

  8. Stundenbogen zur Supervisionsbeurteilung (STEP SV)

    Time frame: participants will be followed for the duration of psychotherapy, an expected average of 30 weeks

    self-report measure that assesses satisfaction with supervision

  9. Cognitive Therapy Scale (CTS)

    Time frame: participants will be followed for the duration of psychotherapy, an expected average of 30 weeks

    clinician-rated measure that assesses psychotherapeutic competencies

Sponsors and collaborators

Lead sponsor

Goethe University

Other

Collaborators

  • Central Institute of Mental Health, Mannheim

Registry information

Official study title

Live Supervision Put to Test - Studies of Acceptance and Efficacy of Computer-assisted Live Supervision

Important dates

Study start
2012
Primary completion
2014
Study completion
2014
First posted
Jan 13, 2012
Registry last updated
Jan 21, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.